UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000029727
Receipt number R000033967
Scientific Title Evaluation of cholesterol reduction effect by ingesting concentrated red malt
Date of disclosure of the study information 2017/10/27
Last modified on 2018/12/26 18:57:40

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Evaluation of cholesterol reduction effect by ingesting concentrated red malt

Acronym

Evaluation of cholesterol reduction effect by ingesting supplement.

Scientific Title

Evaluation of cholesterol reduction effect by ingesting concentrated red malt

Scientific Title:Acronym

Evaluation of cholesterol reduction effect by ingesting supplement.

Region

Japan


Condition

Condition

Healthy adults

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

A placebo-controlled double-blind study was conducted to evaluate the effect of cholesterol reduction by ingesting concentrated red malt. We performed physical measurement, doctor's findings and evaluations, dietary advice, qualification judgment by doctor, health diary, height measurement, blood test, measurement of blood pressure and pulse, diet survey and lifestyle survey.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Blood test(LDL cholesterol)

Key secondary outcomes

Measurement of blood pressure and pulse
Blood test
Diet survey
Doctor's findings and evaluations
Dietary advice
Physical measurement
Health diary


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Food

Interventions/Control_1

Test 2 capsules once once a day after dinner with water

Interventions/Control_2

Placebo 2 capsules once once a day after dinner with water

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

30 years-old <=

Age-upper limit

59 years-old >=

Gender

Male and Female

Key inclusion criteria

1) Japanese males and females aged 30 to 59 years old at the time of acquiring consent on the first observation day (equal males and females)
2) Persons who have increased serum cholesterol

Key exclusion criteria

1) Persons who are taking medications (lipid-lowering drugs, etc.) that are likely to affect the test results
2) Persons routinely taking health foods (supplements with cholesterol-reducing effect, etc.) that are likely to affect the test results
3) Alcohol addiction
4) Persons who are likely to have allergic symptoms depending on the test article component
5) Participating in other clinical trials
6) Persons who have a history of serious liver disorder, kidney disorder, heart disease
7) Persons who have a history of hepatitis or who are currently suffering from hepatitis
8) Persons with serious anemia
9) Persons who are judged inappropriate to participate the study by the supervising doctor (When recognizing the fact that it is determined to be ineligible during the course of the test, it is excluded from the analysis subject. Note that inspection items that are not screening criteria are not an exclusion criterion from screening.)

Target sample size

30


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Takashi Koikeda

Organization

Shiba Palace Clinic

Division name

Chair

Zip code


Address

6F DaiwaA Hamamatucho Bld., 1-9-10 Hamamatsucho, Minato-ku, Tokyo, 105-0013, Japan

TEL

03-5408-1590

Email

jimukyoku@mail.souken-r.com


Public contact

Name of contact person

1st name
Middle name
Last name Ko Masuda

Organization

SOUKEN Co., Ltd

Division name

Management Division

Zip code


Address

3F DaiwaA Hamamatucho Bld., 1-9-10 Hamamatsucho, Minato-ku, Tokyo, 105-0013, Japan

TEL

03-5408-1555

Homepage URL


Email

k_masuda@mail.souken-r.com


Sponsor or person

Institute

Shiba Palace Clinic

Institute

Department

Personal name



Funding Source

Organization

DHC Corporation.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2017 Year 10 Month 27 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2017 Year 09 Month 04 Day

Date of IRB


Anticipated trial start date

2017 Year 10 Month 18 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2017 Year 10 Month 26 Day

Last modified on

2018 Year 12 Month 26 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000033967


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name